|Day Low/High||0.31 / 0.34|
|52 Wk Low/High||0.29 / 1.73|
Overall response rate of 24% seen with no dose limiting toxicity observed
Combination Treatment Continues to Demonstrate Encouraging Signs of Activity
Overall response rate of 25% by RECIST and median overall survival of 15.5 months exceeds response rate and median overall survival reported in pivotal trials of single agent Nexavar
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.